Literature DB >> 26878264

Stabilizing interactions between D666-S1787 and T657-Y1792 at the A2-A3 interface support factor VIIIa stability in the blood clotting pathway.

M Monaghan1, H Wakabayashi1, A E Griffiths1,2, P J Fay1.   

Abstract

UNLABELLED: Essentials Factor VIIIa (FVIIIa) is unstable due to loss of A2; D666 and Y1792 contribute to its stability. We conducted a study to identify the interactions made at these residues at the A2-A3 interface. We present evidence for stabilizing interactions between D666-S1787 and T657-Y1792 in FVIIIa. A D666C/S1788C variant with a disulfide A2-A3 linkage has a FVIIIa decay rate that is 1% of wild-type.
SUMMARY: Background Factor (F)VIIIa activity and stability depends on the non-covalent association of the A2 subunit with the A1/A3C1C2 dimer, but the interactions that contribute to A2 association are not well defined. Previous work had shown that D666A and Y1792F mutations at the A2-A3 interface resulted in increased FVIIIa decay, suggesting that the residues were involved in bonding interactions important for FVIIIa stability. Objectives Several potential hydrogen bonding partners of D666 and Y1792 across the A2-A3 interface were selected from the low-resolution FVIII crystal structure, and we used mutagenesis and biochemical analysis to examine the bonding interactions occurring at D666 and Y1792. Methods Using a series of stability and functional analyses, we analyzed FVIII variants in which D666 and Y1792 were each swapped with the residues of potential bonding partners. Results and conclusions We present evidence for hydrogen bonds between D666 and S1787 and between Y1792 and T657 that are important for FVIIIa stability. D666S/S1787D and T657Y/Y1792T variants each displayed wild-type (WT)-like FVIIIa stability and performed like WT FVIII in a series of functional analyses, whereas D666S, S1787D, and Y1792T single variants showed increased FVIIIa decay and a T657Y variant had little FVIIIa activity. These results suggest that WT hydrogen bonds are disrupted with the single mutations but maintained in the swap variants. Furthermore, mutation of D666 and S1788 to cysteine resulted in disulfide bond formation across the A2-A3 interface, confirming the close proximity of D666 and S1787, and this covalent attachment of the A2 subunit significantly increased FVIIIa stability.
© 2016 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  blood coagulation; factor VIII; factor VIIIa; protein stability; site-directed mutagenesis

Mesh:

Substances:

Year:  2016        PMID: 26878264      PMCID: PMC4870127          DOI: 10.1111/jth.13292

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  40 in total

1.  Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor VIIIa.

Authors:  P J Fay; T M Smudzin
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

2.  Mutations in a subgroup of patients with mild haemophilia A and a familial discrepancy between the one-stage and two-stage factor VIII:C methods.

Authors:  Z Rudzki; E M Duncan; G J Casey; M Neumann; E J Favaloro; J V Lloyd
Journal:  Br J Haematol       Date:  1996-08       Impact factor: 6.998

3.  A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin.

Authors:  S Pemberton; P Lindley; V Zaitsev; G Card; E G Tuddenham; G Kemball-Cook
Journal:  Blood       Date:  1997-04-01       Impact factor: 22.113

4.  pH-dependent denaturation of thrombin-activated porcine factor VIII.

Authors:  P Lollar; C G Parker
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

5.  Structural basis for the decreased procoagulant activity of human factor VIII compared to the porcine homolog.

Authors:  P Lollar; E T Parker
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

6.  Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunit.

Authors:  P J Fay; P J Haidaris; T M Smudzin
Journal:  J Biol Chem       Date:  1991-05-15       Impact factor: 5.157

Review 7.  Thrombin generation in plasma: its assessment via the endogenous thrombin potential.

Authors:  H C Hemker; S Béguin
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249

8.  Coagulant properties of hybrid human/porcine factor VIII molecules.

Authors:  P Lollar; E T Parker; P J Fay
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

9.  Familial discrepancy between the one-stage and two-stage factor VIII methods in a subgroup of patients with haemophilia A.

Authors:  E M Duncan; B M Duncan; L J Tunbridge; J V Lloyd
Journal:  Br J Haematol       Date:  1994-08       Impact factor: 6.998

10.  Isolation and characterization of thrombin-activated human factor VIII.

Authors:  J E Curtis; S L Helgerson; E T Parker; P Lollar
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

View more
  1 in total

1.  The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain.

Authors:  Ian W Smith; Anne E d'Aquino; Christopher W Coyle; Andrew Fedanov; Ernest T Parker; Gabriela Denning; Harold Trent Spencer; Pete Lollar; Christopher B Doering; Paul Clint Spiegel
Journal:  J Thromb Haemost       Date:  2019-09-08       Impact factor: 5.824

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.